MTOR and neoplasm: Selective arterial embolization can rapidly achieve hemostasis while preserving renal function, though it carries risks such as postoperative pain, recurrent bleeding, and tumor recurrence.mTOR inhibitors, such as everolimus, can reduce tumor volume and decrease the risk of bleeding; however, they require long-term administration and are associated with adverse effects including immunosuppression (25).